NIH Blueprint MedTech Translator
Funds translational neurotechnology device development through structured milestones and multi-year collaboration.
The NIH Blueprint MedTech Translator, issued under NOFO PAR-25-383, funds translational development of therapeutic and diagnostic devices targeting nervous system and neuromuscular disorders. The program uses the UG3/UH3 cooperative agreement mechanism, which is a milestone-driven two-phase structure: the UG3 planning phase must achieve pre-specified milestones before NIH releases UH3 implementati…
Translational activities and clinical feasibility studies for therapeutic and diagnostic devices targeting nervous system and neuromuscular disorders.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline